Taiwan FDA registration 013a954268dd43a471fb1b4d703a04b9
Reap cortisol detection reagent
TW: 禮亞尚皮質醇檢測試劑
Taiwan·Risk Class 2·DIASORIN ITALIA S.P.A.·Registered Dec 13, 2012 – Dec 13, 2027ActiveRegistration details
- Analysis ID
- 013a954268dd43a471fb1b4d703a04b9
- Customs Code
- DHA00602429409
Company information
- Manufacturer
- DIASORIN ITALIA S.P.A.
- Manufacturer Country
- Italy
- Authorized Representative
- EVERLIGHT BIOTECH(TAIWAN) CO., LTD.
Product details
- Intended Use
- This product is an in vitro assay for the quantification of cortisol in human serum, plasma or urine. It must be used in conjunction with the LIAISON Analyzer for detection and analysis.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1205 Cortisol (hydronephrine, and hydroxycortisol) test system
- Import Information
- import
Dates and status
- Registration Date
- Dec 13, 2012
- Expiry Date
- Dec 13, 2027
About this record
Access comprehensive regulatory information for Reap cortisol detection reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 013a954268dd43a471fb1b4d703a04b9 and manufactured by DIASORIN ITALIA S.P.A.. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices